Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.
TRANSLATIONAL RESEARCH IN PRACTICE: a PKC-beta inhibitor for diabetic retinopathy
Donnelly
R
R
School of Medical and Surgical Sciences, University of Nottingham, Derbyshire Royal Infirmary, Derby DE1 2QY, UK. Richard.donnelly@nottingham.ac.uk
Idris
I
I
Forrester
J V
JV
D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000201:enzymology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008301:Maleimides / Q000627:therapeutic use; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000502:physiology; D016032:Randomized Controlled Trials as Topic; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; D042461:Vascular Endothelial Growth Factor A; C099154:ruboxistaurin; D011493:Protein Kinase C